---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-077790"
form_type: "8-K"
ticker: "SMNR"
cik: "0001913577"
company_name: "Semnur Pharmaceuticals, Inc."
filed_at: "2024-09-12T23:59:59+00:00"
generated_at: "2026-05-31T05:18:42.610015+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Denali Capital extends business combination deadline to Oct 11, 2024 via trust deposit

## Summary
- Deposited $15,063.74 into trust to extend deadline one month from Sept 11 to Oct 11, 2024.
- Funding from Scilex Holding (SCLX) convertible promissory note up to $180,000, zero interest.
- Note convertible into DECA Class A shares at $10.00 per share upon business combination close.
- Remaining $149,899.52 of note principal available to fund further monthly extensions.

## SEC filing metadata
- accession: 0001213900-24-077790
- form_type: 8-K
- ticker: SMNR
- cik: 0001913577
- company_name: Semnur Pharmaceuticals, Inc.
- filed_at: 2024-09-12T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1913577/000121390024077790/0001213900-24-077790-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1913577/000121390024077790/ea0214299-8k425_denali.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-077790
- JSON: https://secwatch.observer/filing/0001213900-24-077790.json
- Plain text: https://secwatch.observer/filing/0001213900-24-077790.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.